JCJan Chrz

Jan Chrz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jan Chrz has a total of 19 co-authors. Here are the top co-authors by number of shared publications:

  • A Vlková

    National Institute of Public Health, Centre of Toxicology and Health Safety, Prague, Czech Republic

    1 shared publication
  • B Hošíková

    Department of Medical Biophysics, Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University in Olomouc, Czech Republic

    1 shared publication
  • Barbora Hosikova

    Department of Medical Biophysics, Faculty of Medicine and Dentistry, Palacky University, 77900 Olomouc, Czech Republic

    1 shared publication
  • D Očadlíková

    National Institute of Public Health, Centre of Toxicology and Health Safety, Prague, Czech Republic

    1 shared publication
  • Dagmar Jirova

    Centre of Toxicology and Health Safety, National Institute of Public Health, Šrobárova 49/48, 100 00 Prague, Czech Republic

    1 shared publication
  • Danuše Očadlíková

    Centre of Toxicology and Health Safety, National Institute of Public Health, Šrobárova 49/48, 100 00 Prague, Czech Republic

    1 shared publication

Latest Publications

  • Open Access

    The Potential for Genotoxicity, Mutagenicity and Endocrine Disruption in Triclosan and Triclocarban Assessed through a Combination of In Vitro Methods

    by Jan Chrz, Markéta Dvořáková, Kristina Kejlová, Danuše Očadlíková, Lada Svobodová, Lukáš Malina, Barbora Hošíková, Dagmar Jírová, Hana Bendová, Hana Kolářová

    Triclosan and Triclocarban, preservatives widely used in cosmetics and other consumer products, underwent evaluation using a battery of new-approach methodologies in vitro (NAMs). Specifically, the Microplate Ames Test (MPF™ Test, Xenometrix, Allschwil, Switzerland) was employed to assess mutagenicity, the Comet assay in vitro on the HaCat cell line and the Mammalian Chromosome Aberration Test were utilized to evaluate genotoxicity, and the XenoScreen® YES/YAS assay was applied to investigate endocrine disruption. The chemicals did not exhibit any positive responses for mutagenicity. However, the mammalian chromosome aberration test identified both chemicals as being positive for genotoxicity at 10 µg/mL. In the Comet assay, the percentage of DNA in the tail significantly increased in a concentration-dependent manner (at 5 and 10 µg/mL for Triclosan, at 2.5, 5, and 10 µg/mL for Triclocarban). The positive response depended on the increasing concentration and the duration of exposure. Triclosan, but not Triclocarban in any of the endocrine assays performed, indicated a potential for endocrine activity in the anti-estrogenic and anti-androgenic assays. The positive in vitro results detected were obtained for concentrations relevant to final products. The alarming findings obtained with the use of new-approach methodologies (NAMs) justify the current precautionary regulatory approach, limiting the use of these preservatives.


  • Comparison of methods used for evaluation of mutagenicity/genotoxicity of model chemicals - parabens

    by J Chrz, B Hošíková, L Svobodová, D Očadlíková, H Kolářová, M Dvořáková, K Kejlová, L Malina, G Jírová, A Vlková, et al.

    Growing worldwide efforts to replace (reduce) animal testing and to improve alternative in vitro tests which may be more efficient in terms of both time, cost and scientific validity include also genotoxicity/mutagenicity endpoints. The aim of the review article was to summarize currently available in vitro testing approaches in this field, their regulatory acceptance and recommended combinations for classification of chemicals. A study using the combination of Comet Assay performed on two cell lines and the Chromosomal Aberration test on human peripheral lymphocytes was performed with the aim to predict the genotoxic potential of selected paraben esters, serving as a model chemical group. Parabens are widely used in consumer products as preservatives and have been reported to exhibit inconclusive results in numerous genotoxicity studies. The Comet Assay identified Ethylparaben and Benzylparaben as potentially genotoxic. The Chromosomal Aberration test revealed weak genotoxic potential in case of Ethylparaben and positive genotoxicity in case of Butylparaben, Propylparaben and Isopropylparaben. The main reasons for variability seem to be limited water solubility of parabens, determining their bioavailability at the cellular level, and absence of metabolic activation in the Comet Assay. The results confirmed that the Comet Assay should serve as a screening test and should not be used as a stand-alone method for classification of genotoxicity. The weight of evidence approach in risk assessment should be supported with data generated with the use of human relevant in vitro methods based on cells / tissues of human origin.